Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary
Tilmann Bochtler, Anna Reiling, Volker Endris, Thomas Hielscher, Anna Lena Volckmar, Olaf Neumann, Martina Kirchner, Jan Budczies, Lukas C. Heukamp, Jonas Leichsenring, Michael Allgäuer, Daniel Kazdal, Harald Löffler, Wilko Weichert, Peter Schirmacher, Albrecht Stenzinger, Alwin Krämer
Research output: Contribution to journal › Article › peer-review
16Scopus
citations
Fingerprint
Dive into the research topics of 'Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary'. Together they form a unique fingerprint.